Inspire Investing LLC invests $357,000 in STERIS plc (NYSE: STE)
Inspire Investing LLC bought a new position in shares of STERIS plc (NYSE: STE – Get a rating) in Q1, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The company bought 1,475 shares of the medical equipment supplier, valued at around $357,000.
A number of other institutional investors and hedge funds have also recently changed their positions in STE. Riverview Trust Co purchased a new stake in STERIS in Q1 worth approximately $29,000. Destiny Wealth Partners LLC purchased a new equity stake in STERIS during the fourth quarter at a value of $64,000. Quent Capital LLC acquired a new stake in STERIS during the fourth quarter at a value of $72,000. AdvisorNet Financial Inc increased its stake in STERIS by 34.3% in the fourth quarter. AdvisorNet Financial Inc now owns 309 shares of the medical equipment supplier worth $75,000 after buying 79 more shares in the last quarter. Finally, Aquire Wealth Advisors LLC acquired a new position in STERIS in Q4 worth approximately $93,000. 90.88% of the shares are currently held by hedge funds and other institutional investors.
Several equity research analysts have recently commented on the company. StockNews.com upgraded STERIS from a “hold” to a “buy” rating in a Wednesday, June 15 research note. TheStreet downgraded STERIS shares from a “b-” rating to a “c” rating in a Thursday, June 16 research report. Finally, Wolfe Research began covering STERIS shares in a report on Tuesday, April 5. They set an “outperform” rating and a price target of $275.00 for the stock. Seven research analysts rated the stock with a buy rating. According to MarketBeat, the stock currently has a consensus buy rating and a consensus target price of $264.00.
In other news, VP Jean-Adam Zangerle sold 8,000 shares of the company in a trade dated Wednesday, April 20. The stock was sold at an average price of $255.48, for a total value of $2,043,840.00. Following the sale, the vice president now directly owns 31,023 shares of the company, valued at $7,925,756.04. The sale was disclosed in an SEC filing, available at the SEC website. In the past ninety days, insiders have sold 18,659 shares of the company worth $4,589,759. 1.14% of the shares are currently held by insiders of the company.
NYSE ST opened at $210.96 on Tuesday. STERIS plc has a fifty-two week low of $192.40 and a fifty-two week high of $255.93. The stock’s 50-day moving average is $217.87 and its two-hundred-day moving average is $229.13. The company has a debt ratio of 0.45, a current ratio of 2.04 and a quick ratio of 1.41. The company has a market capitalization of $21.11 billion, a P/E ratio of 88.27 and a beta of 0.70.
STERIS (NYSE: STE – Get a rating) last reported results on Wednesday, May 11. The medical equipment supplier reported earnings per share of $2.04 for the quarter, beating the consensus estimate of $2.00 by $0.04. STERIS has a return on equity of 11.85% and a net margin of 5.32%. The company posted revenue of $1.21 billion for the quarter, compared to analysts’ estimates of $1.18 billion. On average, equity analysts expect STERIS plc to post an EPS of 8.7 for the current year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, June 28. Shareholders of record on Tuesday, June 14 received a dividend of $0.43 per share. The ex-dividend date was Monday, June 13. This represents an annualized dividend of $1.72 and a yield of 0.82%. STERIS’ dividend payout ratio (DPR) is currently 71.97%.
About STERIS (Get a rating)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences and Dental. The Healthcare segment offers cleaning chemicals and sterility assurance products; automated endoscope reprocessing system and follow-up products; accessories for gastrointestinal (GI) procedures, washers, sterilizers and other capital goods for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights and connectivity solutions, as well as equipment management services.
Want to see what other hedge funds hold STE? Visit HoldingsChannel.com for the latest 13F filings and insider trading for STERIS plc (NYSE: STE – Get a rating).
Get news and reviews for STERIS Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for STERIS and related companies with MarketBeat.com’s free daily email newsletter.
Comments are closed.